Managers / Q2 2019 · view latest →
FALCON POINT CAPITAL, LLC
CIK 0001251557 · TWO EMBARCADERO CENTER STE 420, SAN FRANCISCO, CA, 94111 · 4157829600
Summary
Falcon Point Capital, LLC reported $186M in U.S.-listed holdings across 105 positions for Q2 2019.
Its largest position, Cardiovascular Systems, represents 3.7% of the portfolio.
Compared with Q1 2019, the fund opened 10 new positions and exited 11.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 77.9% · $145M
- Other · 17.2% · $32M
- Ltd Part · 2.8% · $5M
- US DOMESTIC · 0.9% · $2M
- PUBLIC · 0.8% · $1M
- Other · 0.3% · $568,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| IIVI Inc. | NEW | +65.5K | 65.5K | +$2M | $2M |
| BVBrightView Holdings Inc. | NEW | +124.5K | 124.5K | +$2M | $2M |
| Monotype Imaging Holdings Inc. | NEW | +22.1K | 22.1K | +$372,000 | $372,000 |
| VCYTVeracyte Inc. | NEW | +11.9K | 11.9K | +$340,000 | $340,000 |
| Scorpio Tankers Inc | NEW | +250.0K | 250.0K | +$260,000 | $260,000 |
| XENEXenon Pharmaceuticals INC | NEW | +25.6K | 25.6K | +$252,000 | $252,000 |
| Kirkland Lake Gold | NEW | +4.8K | 4.8K | +$207,000 | $207,000 |
| AGIAlamos Gold, Inc. | NEW | +26.3K | 26.3K | +$159,000 | $159,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2020 | $12M | 45 | Jan 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $9M | 38 | Oct 22, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $20M | 65 | Jul 21, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $46M | 95 | Apr 22, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $79M | 109 | Jan 23, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $183M | 108 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $186M | 105 | Jul 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $184M | 106 | May 8, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- SEI INVESTMENTS MANAGEMENT CORP028-16475
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.